Bicara Therapeutics - Bathi operasional EBITDA BCAX
Is it worth investing in innovative antibodies that attack tumors from within? The consolidated EBITDA provides the answer, with the latest parameter standing at 0.00. The Bicara Therapeutics Inc. (BCAX) model relies on outsourced drug manufacturing to avoid capital expenditures. While development focuses on head and neck cancer therapy, business growth currently depends entirely on FDA verdicts.
Bicara Therapeutics (BCAX) - rincian metrik lan laporan keuangan
- kuotasi saiki lan rata-rata prakiraan nilai:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas Bicara Therapeutics Inc.|BCAX - Utang jangka dawa marang modal|Koefisien utang jangka cendhak marang modal Bicara Therapeutics Inc|BCAX - Gunggung utang perusahaan|Utang marang nilai buku Bicara Therapeutics|BCAX - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Bicara Therapeutics|Rasio jangkoan perantara bicara.com
- statistik bathi lan rasio pasar:
BCAX - Bathi resik|Proyeksi bathi mangsa ngarep Bicara Therapeutics Inc.|BCAX - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi bicara.com|BCAX - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Bicara Therapeutics|BCAX - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Bicara Therapeutics|BCAX - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan bicara.com|BCAX - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Bicara Therapeutics Inc.
Ringkesan analitik perusahaan:BCAX - Bicara Corp
This indicator reflects the actual cash flow from operating activities before deducting financial expenses and depreciation. By analyzing earnings before interest, taxes, depreciation, and amortization, the investor assesses the business's ability to generate liquidity regardless of its debt load. The metric aggregates operating income and non-cash charges, excluding the impact of the tax regime. Positive dynamics confirm the effective management of the ficlatuzumab clinical pipeline. The high scientific expertise of Bicara Therapeutics Inc. (BCAX) management ensures transparent capital deployment.
Karo sapa Bicara Therapeutics Inc. saingan
ONC - Bathi operasional sadurunge ngurangi amortisasi|HALO: Bathi operasional sadurunge ngurangi amortisasi|RVMD - Bathi operasional EBITDA|Ascentage Pharma (AAPG) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|CG Oncology Inc - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|URGN (UroGen) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Personalis Genomics PSNL|Bathi operasional EBITDA ERAS|Bathi sadurunge mbayar bunga, pajak, lan amortisasi DCTH (delcath.com)|Bathi operasional EBITDA YMAB (Y-mAbs Therapeutics, Inc.)|Pendapatan operasional sadurunge ngurangi amortisasi Aura Biosciences Inc (AURA)|Candel - Bathi operasional EBITDA|Accuray, Inc. (ARAY) - Bathi operasional sadurunge ngurangi amortisasi|SLS: Bathi operasional EBITDA|actuatetherapeutics.com (ACTU) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Citius Oncology|HURA: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TARA|Bathi operasional EBITDA Fate Pharma (FATE)|Aadi Bioscience - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi TCRX|CSBR: Bathi operasional sadurunge ngurangi amortisasi|XBiotech Inc. - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|CVM: Bathi operasional EBITDA|OS Therapies, Inc. - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|RADX (Radiopharm Theranostics) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Artiva ARTV|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Adlai Nortye Ltd. (ANL)|VERU (Veru Inc) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA TPST (Tempest Tx)|Bathi operasional EBITDA Xilio Therapeutics Inc XLO|RENB - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi MURA|KAPA: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi OnKure Therapeutics (OKUR)|Bathi operasional sadurunge ngurangi amortisasi GDTC|Bathi operasional EBITDA Curis Corp|Bathi operasional sadurunge ngurangi amortisasi APLM (Apollomics, Inc.)|Bathi perusahaan sadurunge pajak, bunga, lan amortisasi THAR|Bathi operasional EBITDA ADVB (Advanced Biomed)|Pendapatan operasional sadurunge ngurangi amortisasi Genprex Inc. (GNPX)|Calidi Bio - Bathi operasional EBITDA|sunshinebiopharma.com (SBFM) - Bathi operasional sadurunge ngurangi amortisasi|xeneticbio.com (XBIO) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLRX - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi operasional sadurunge ngurangi amortisasi PPBT|AONC: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA BGNE|Pendapatan operasional sadurunge ngurangi amortisasi Checkpoint Therapeutics Inc|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Elevation Oncology ELEV|ICAD: Bathi operasional sadurunge amortisasi|Ikena - Bathi operasional EBITDA|Notable Labs Ltd (NTBL) - Bathi operasional sadurunge ngurangi amortisasi|VIRX (viracta.com) - Bathi operasional sadurunge ngurangi amortisasi|MOR - Pendapatan operasional sadurunge ngurangi amortisasi|NAYA (NAYA Biosciences) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi AAPGV
